SAN DIEGO, Dec. 10, 2024 /PRNewswire/ — Robbins LLP announces that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain of the Company’s senior executives and directors who signed the Registration Statement, effective February 7, 2024, issued…